Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Use of virologic assays for detection of human immunodeficiency virus in clinical trials: recommendations of the AIDS Clinical Trials Group Virology Committee.

Hammer S, Crumpacker C, D'Aquila R, Jackson B, Lathey J, Livnat D, Reichelderfer P.

J Clin Microbiol. 1993 Oct;31(10):2557-64. Review. No abstract available.

3.

Standardized peripheral blood mononuclear cell culture assay for determination of drug susceptibilities of clinical human immunodeficiency virus type 1 isolates. The RV-43 Study Group, the AIDS Clinical Trials Group Virology Committee Resistance Working Group.

Japour AJ, Mayers DL, Johnson VA, Kuritzkes DR, Beckett LA, Arduino JM, Lane J, Black RJ, Reichelderfer PS, D'Aquila RT, et al.

Antimicrob Agents Chemother. 1993 May;37(5):1095-101.

4.

Interlaboratory comparison of sequence-specific PCR and ligase detection reaction to detect a human immunodeficiency virus type 1 drug resistance mutation. The AIDS Clinical Trials Group Virology Committee Drug Resistance Working Group.

Shafer RW, Winters MA, Mayers DL, Japour AJ, Kuritzkes DR, Weislow OS, White F, Erice A, Sannerud KJ, Iversen A, Pena F, Dimitrov D, Frenkel LM, Reichelderfer PS.

J Clin Microbiol. 1996 Jul;34(7):1849-53.

5.

[Diagnostic reference. Human immunodeficiency virus].

Porstmann T.

Wien Med Wochenschr. 1992;142(17):396-8. German. No abstract available.

PMID:
1362310
7.

HIV-1 subtype O: epidemiology, pathogenesis, diagnosis, and perspectives of the evolution of HIV.

Gürtler LG, Zekeng L, Tsague JM, van Brunn A, Afane Ze E, Eberle J, Kaptue L.

Arch Virol Suppl. 1996;11:195-202. Review.

PMID:
8800800
8.

Correlation between antiretroviral resistance mutations, biological parameters, and clinical evolution in zidovudine-treated patients infected with human immunodeficiency virus type 1.

Leriche-Guérin K, Trabaud MA, Cotte L, Bissuel F, Deruelle E, Rougier P, Trépo C.

Eur J Clin Microbiol Infect Dis. 1997 Sep;16(9):660-8.

PMID:
9352259
9.

Similar proviral load but increased HIV-1 p24 in the intestinal mucosa compared to the peripheral blood in HIV-infected patients.

Schmidt W, Fackler OT, Schäfer M, Zippel T, Heise W, Mueller-Lantzsch N, Riecken EO, Ullrich R.

Ann N Y Acad Sci. 1998 Nov 17;859:276-9. No abstract available.

PMID:
9928404
10.

HIV virology for clinical trials.

Shafer RW, Merigan TC.

AIDS. 1995;9 Suppl A:S193-202. Review. No abstract available.

PMID:
8819586
11.

AIDS in an HIV-seronegative Ghanaian woman with intersubtype A/G recombinant HIV-1 infection.

Candotti D, Adu-Sarkodie Y, Davies F, Baldrich-Rubio E, Stirrups K, Lee H, Allain JP.

J Med Virol. 2000 Sep;62(1):1-8.

PMID:
10935981
12.
13.
14.

Deterioration of detectable human immunodeficiency virus serum p24 antigen in samples stored for batch testing.

Lathey JL, Marschner IC, Kabat B, Spector SA.

J Clin Microbiol. 1997 Mar;35(3):631-5.

15.

Could the new HIV combined p24 antigen and antibody assays replace p24 antigen specific assays?

Ly TD, Ebel A, Faucher V, Fihman V, Laperche S.

J Virol Methods. 2007 Jul;143(1):86-94. Epub 2007 Mar 28.

PMID:
17395277
16.
17.

[A comparative study of technics for the diagnosis of the human immunodeficiency virus in infants under 15 months by: viral cultivation, the polymerase chain reaction and antigen p24].

Muñoz Fernández MA, Obregón González E, Navarro Caspistegui J, Gurbindo Gutiérrez MD, Hernández Sampelayo T, Fernández-Cruz E.

An Esp Pediatr. 1996 Jun;44(6):540-4. Spanish.

PMID:
8849094
18.

Use of genotypic assays for the detection of HIV antiretroviral resistance.

Nicastri E, Ippolito G.

Scand J Infect Dis Suppl. 2003;106:24-8. Review.

PMID:
15000578
19.

Evaluation of a quality assurance program for quantitation of human immunodeficiency virus type 1 RNA in plasma by the AIDS Clinical Trials Group virology laboratories.

Yen-Lieberman B, Brambilla D, Jackson B, Bremer J, Coombs R, Cronin M, Herman S, Katzenstein D, Leung S, Lin HJ, Palumbo P, Rasheed S, Todd J, Vahey M, Reichelderfer P.

J Clin Microbiol. 1996 Nov;34(11):2695-701.

20.

Absence of detectable antibody in a patient infected with human immunodeficiency virus.

Reimer L, Mottice S, Schable C, Sullivan P, Nakashima A, Rayfield M, Den R, Brokopp C.

Clin Infect Dis. 1997 Jul;25(1):98-100.

Items per page

Supplemental Content

Write to the Help Desk